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Abstract
We investigated the anti-tumor effects of Verbena officinalis extract on H22 tumor-bearing mice and its effect on
immune function. Mice model of H22 solid tumor was established, the mice were divided into five groups and administered
the extract, later, tumors were removed and inhibition rates were calculated; spleens were removed and spleen indices were
calculated, and the sheep red blood cell-delayed-type hypersensitivity (SRBC-DTH) and the serum hemolysin level were
determined. The Verbena officinalis extract had anti-tumor effect, with the inhibition rate reaching 38.78%, it also increased
the spleen index to a certain extent, in addition, the changes in DTA and HA were not obvious compared with the model
group. The Verbena officinalis extract had in vivo anti-tumor effect, while causing no damage on the immune function.
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Introduction
Verbena officinalis is the dried aerial parts of Verbena officinalis L. and bought from Zaoyang City in Hubei province,
which belongs to the Verbenaceae family (Chinese Pharmacopoeia Commission, 2010), it is mainly used for the treatment of
abdominal mass, amenorrhea, dysmenorrhea, malaria, pharyngitis, carbuncles, edema, etc. The main chemical constituents of
Verbena officinalis include iridoid glycosides such as verbenalin and its derivatives (Tian et al., 2005; Zhang et al.,
2000), and flavonoid compounds such as luteolin, kaempferol (Chen et al., 2006), ursolic acid (Ma et al., 2005), and volatile
oils (Khaled et al., 2010). Studies on its pharmacological activities have mainly focused on the anti-inflammatory (Calvo et
al., 2006; Vilalta et al., 1998; M.I. Calvo, N et al., 1998)(not in the references list), antitussive (Gui et al., 1985) effects as
well as the effect on uterine smooth muscle (Reproductive Physiology Group i et al., 1974), recent studies have reported the
inhibitory effect of Verbena officinalis extract on human choriocarcinoma JAR cells and its mechanism of action has been
studied (Xu et al., 2001; Zhang et al., 2005; Wang et al., 2004). In this paper, the anti-tumor effect of Verbena officinalis
extract was studied with the mice H22 hepatoma ascites as the animal model, and its anti-tumor mechanism was initially
investigated.
Materials and Methods
Drugs and Reagents
Verbena officinalis (Baidu Medical Co., Ltd.); cisplatin (Qilu Pharmaceutical Co., Ltd.); SRBC (sterile sheep blood,
after defiberization, stored at a 4 oC refrigerator for later use).
Apparatus
FM-2000A dual-head gamma immune counter (Xi'an Kaipu Mechanical & Electrical Equipment Co., Ltd.); AE31
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inverted phase contrast microscope (Motic); SW-CJ-IF Clean Bench (Suzhou Purification Equipment Co., Ltd.);
low-temperature refrigerated centrifuge (Eppendorf, Germany); electronic balance (Beijing Sartorius Instrument System Co.,
Ltd.); blood cell counting chamber (Shanghai Qiujing Biochemical Instrument Co., Ltd.).
Animals
Kunming mice, half male and half female, weight 18~22 g, purchased from the Laboratory Animal Center of the China
Medical University. H22 Mice Ascites Hepatoma Cell Lines, purchased from Nanjing KeyGen Biotech. Inc. All experimental
animals were approved by the Animal Research Ethics Committee of Xinxiang Medical University, Henan,
China(XXMU809).
Preparation of Verbena Officinalis Extract
Dried Verbena officinalis herb was crushed and adequate (2 kg) was weighed out, which was then added with
distilled water 25 times its volume, and extracted for three times using water bath reflux with 2 h each, the extracts
were combined together, and after freeze-drying, Verbena officinalis extract powder was obtained. The dried
powder was diluted to required concentrations when needed.
Cell Cultivation
Single cell suspension was prepared, the number of cells was adjusted to 1×106, which was seeded to the peritoneal
cavity of mice under sterile conditions (0.2 mL/mouse), and abdominal swelling of the mice was observed on a daily basis. 6
days later, peritoneal effusions in mice were extracted.
Model Building (Li et al., 2006)
The mice, whose abdominal circumferences were increased to maximum on the 6th day of inoculation, were sacrificed
by cervical dislocation, after disinfection of the abdomen, abdominal cavity was cut open, and ascitic fluid was extracted
with 1-mL sterile syringes, the ascitic fluid was diluted with PBS and centrifuged at 1000 rpm/min for 10 min, the
supernatant was discarded, and viable cells were counted using the trypan blue dye exclusion assay, the number of tumor
cells were adjusted to 1×106 cells/mL. 50 mice were selected and their right armpit skins were disinfected, tumor cell
suspension was injected subcutaneously to the right forelimb armpit of each mouse using 1-mL sterile syringes ( 0.2
mL/mouse) to create a solid tumor model.
Grouping and Administration
24 hours after inoculation, the 50 mice were randomly divided into 5 groups, namely the model group, cisplatin group,
high-, medium- and low-dose verbena officinalis extract groups (n=10). All mice were provided with enough water and food,
while mice in each group were weighed and their body weights were recorded. The administration and dosage were
determined in accordance with the “Experimental Methodology of Pharmacology” (Xu et al., 1991), high-, medium- and
low-dosages of verbena officinalis were 40, 20, and 10 g crude drug/Kg respectively. The mental state, activities and dietary
intake of mice were observed on a daily basis.
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Determination of Body Weight
Before and after the experiment, mice in each group were weighed and their body weights were recorded.
Determination of Tumor Inhibition Rate
24 h after the last administration, mice were sacrificed, tumors were peeled off and weighed, and the tumor inhibition
rate was calculated according to the following formula. Tumor inhibition rate = (average tumor weight of control group -
average tumor weight of experimental group) / average tumor weight of control group × 100%
Determination of Spleen Index
After the mice were sacrificed, their spleens were removed and weighed. The ratio between spleen
weight (mg) and body weight (g) was taken as the spleen index.
Determination of Footpad Swelling (DTH) and Serum Hemolysin Level
Footpad swelling (DTH) was determined by the footpad swelling method (Cao et al., 2009): Fresh defibered sheep
blood was washed with sterile normal saline for three times, and prepared as 2% SRBC, on the 3rd day of the experiment, 0.2
ml of the 2% SRBC was injected intraperitoneally to each mouse to cause immunization, on the 4th day after immunization,
the thicknesses of left and right footpads were measured with a vernier caliper, and 20% SRBC (20 ul/mouse) was injected
subcutaneously at the measured site to induce the attack, 24 h after the attack, thicknesses of left and right footpads were
measured, each site was measured for three times and the average value was obtained. DTH degree was represented by
difference in thickness of front and rear footpads (footpad swelling) before and after the attack.
Serum hemolysin level was determined by the micro-hemagglutination assay (Xue et al., 1995). On the 3rd day of
administration, each mouse was injected intraperitoneally with 0.2 ml of 2% SRBC, 24 h after the last administration, mice
eyeballs were enucleated and blood was extracted, serum was obtained by centrifugation, and serum hemolysin level was
determined on the U-shaped 96-well microplate, the highest serum dilution factor showing (++) agglutination was
taken as the hemolysin titer.
Statistical Methods
The experimental data was analyzed using the SPSS 13.0 software. T-test was used for the comparison between
two groups, and pairwise comparisons among groups were performed using the One-way analysis of
variance (ANOVA).
Results
Effect of Verbena Officinalis Extract on Body Weight of Mice
The changes in body weights of mice before and after the experiment were as shown in Table 1, body weights
increased markedly in all of the experimental groups except for the cisplatin group, but the increases were all smaller
compared with the model group, and the amounts of increase were generally negatively correlated with the dosage.
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Table 1: Effect of Verbena Officinalis Extract on Body Weight Changes of H22 Tumor-Bearing Mice Before and
After Experiment (
—
X ±S, n=10)
Group Dosage (g crude
drug/Kg)
Number of
animals
Average body weight of
mice before the
experiment (g)
Average body weight
of mice after the
experiment (g)
Model - 10 22.58±2.63 28.46±4.24
Cisplatin 1mg/kg 10 22.52±2.38 25.24±3.67
High-dose 40 10 22.57±2.49 27.65±4.45
Medium-dose 20 10 22.76±2.73 27.85±4.85
Low-dose 10 10 22.13±2.43 29.23±5.34
Effect of Verbena Officinalis Extract on Tumor Weight and Tumor Inhibition Rate
The results for the effect of Verbena officinalis extract on tumor weight and tumor inhibition rate were as
shown in Table 2, tumor weights between the model group and high-dose Verbena officinalis group had a very
significant difference (P<0.01), tumor weights between the model group and medium-dose Verbena officinalis
group also had a significant difference (P<0.05), moreover, the tumor inhibition rate for the high-dose group was
greater than 30%, suggesting that the Verbena officinalis extract had an obvious inhibitory effect on H22 solid
tumor in mice. Compared with the model group, tumor weight was also reduced in the low-dose Verbena
officinalis group, but there was no significant difference.
Table 2: Effect of Verbena Officinalis Extract on Tumor Weight and Tumor Inhibition Rate
Group Dosage
(g crude drug/Kg)
Number of
animals
Tumor weight
(g)
Inhibition rate
(%)
Model - 10 3.12±0.98 -
Cisplatin 1mg/kg 10 1.78±0.74** 42.94
High-dose 40 10 1.91±0.38** 38.78
Medium-dose 20 10 2.24±0.84* 28.20
Low-dose 10 10 2.63±1.24 15.71
Comparison with the model group, * P<0.05; ** P<0.01
Effect of Verbena Officinalis Extract on Spleen Index of H22 Tumor-Bearing Mice
The effect of Verbena officinalis extract on spleen index of H22 tumor-bearing mice was as shown in
Table 3-3, compared with the model group, spleen indices of the high- and medium-dose Verbena officinalis
groups were both increased, but the differences were not significant, suggesting that the Verbena officinalis
extract had no significant effect on spleen index of tumor-bearing mice.
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Table 3: Effect of Verbena Officinalis Extract on Spleen Index of H22 Tumor-Bearing Mice
Group Spleen index (mg/g)
Model 5.21±1.65
Cisplatin 5.56±1.82
High-dose 5.79±1.13
Medium-dose 5.23±1.06
Low-dose 5.17.±1.54
Results of Determination of Footpad Swelling (DTH) and Serum Hemolysin Level
The effects of Verbena officinalis extract on footpad swelling (DTH) and serum hemolysin level of mice were as shown
in Table 4, compared with the model group, DTH in each group were increased, but the increase was not
significant. HA content in the cisplatin group showed significant difference compared with the model group, while
HA content in treatment groups showed no significant differences, indicating that the Verbena officinalis extract had no
significant suppressive effects on delayed-type hypersensitivity response to SRBC and on antibody production against SRBC,
Verbena officinalis could inhibit the tumor growth, while causing no apparent damage to the immune organs, cellular
immunity and humoral immune functions.
Table 4: Effect of Verbena Officinalis Extract on Footpad Swelling (DTH) and Serum Hemolysin Level of Mice (
—
X ±S)
Group Dosage
(g crude drug/Kg)
Number
of animals
DTH (0.1 mm) HA (log)
Model - 10 3.54±1.52 3.24±0.21
Cisplatin 1mg/kg 10 3.89±1.59 2.15±0.52*
High dose 40 10 3.61±1.49 2.58±0.28
Medium dose 20 10 3.72±1.82 2.74±0.32
Low-dose 10 10 3.85±1.58 2.96±0.49
Comparison with the model group, *P<0.05
Discussion
Although conventional tumor therapies can kill the tumor cells, they may also cause damage to the body or even further
suppress the immune function. Herbal medicine is China’s traditional medicine, which has become a research focus with its
advantages such as low toxic and side effects, and acceptable tumor inhibitory effect. As a traditional Chinese herbal
medicine, Verbena officinalis is abundant in resources, which is widely distributed in China, the study on its anti-tumor
activity has a broad prospect. There was also a new triterpenoid compound extracted from Verbena officinalis L. which
exhibits significantly higher antitumor activity against human hepatoma cell line Bel 7402 in vitro (Shu et al., 2012). At the
same time, verbenoside A (1) and verbenoside B (2), have been isolated from the ethanol extract of the aerial parts of Verbena
officinalis L (Xu et al., 2010).
This study demonstrated that the Verbena officinalis extract could inhibit the tumor growth in H22 tumor-bearing
mice, and on the basis of its in vivo anti-tumor effect, its effect on immune function was further explored, and was initially
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confirmed that the extract will not damage the immune function. Further in-depth studies should be conducted to clarify its
exact mechanisms of action.
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